Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler and pulse contour analysis and monitoring platform. It offers dopplink, a patient interface cable; and pressurewave, an arterial blood pressure signal under the TrueVue brand. The company also provides oesophageal doppler monitoring systems. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.
Frequently asked questions
What sector does Deltex Medical Group plc (DTXMF) operate in?
Deltex Medical Group plc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Deltex Medical Group plc (DTXMF) current stock price?
As of the latest data, Deltex Medical Group plc stock price is $0.10, with a previous close of $0.10.
What is Deltex Medical Group plc (DTXMF) current market capitalization?
Deltex Medical Group plc market cap is approximately 180.58 million.
Does Deltex Medical Group plc (DTXMF) pay dividends?
No. Deltex Medical Group plc does not pay a dividend.
What is Deltex Medical Group plc (DTXMF) beta (volatility) score?
Deltex Medical Group plc has a beta of -2.063, indicating lower volatility than the overall market.